| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Lafaille Stephen | VP of Business Development | 76 TREBLE COVE ROAD, NORTH BILLERICA | /s/ Stephen Lafaille | 24 Jun 2025 | 0002074096 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TGEN | Common Stock | Purchase | $1,000 | +400 | $2.50 | 400 | 03 Mar 2025 | Direct | ||
| transaction | TGEN | Common Stock | Exercise of in-the-money or at-the-money derivative security | $7,100 | +10,000 | +2500% | $0.7100 | 10,400 | 03 Jun 2025 | Direct | F1 |
| transaction | TGEN | Common Stock | Sale | $48,800 | -10,000 | -96% | $4.88 | 400 | 03 Jun 2025 | Direct | F2 |
| transaction | TGEN | Common Stock | Exercise of in-the-money or at-the-money derivative security | $10,650 | +15,000 | +3750% | $0.7100 | 15,400 | 04 Jun 2025 | Direct | F1 |
| transaction | TGEN | Common Stock | Sale | $75,000 | -15,000 | -97% | $5.00 | 400 | 04 Jun 2025 | Direct | F3 |
| transaction | TGEN | Common Stock | Exercise of in-the-money or at-the-money derivative security | $27,500 | +25,000 | +6250% | $1.10 | 25,400 | 06 Jun 2025 | Direct | F4 |
| transaction | TGEN | Common Stock | Sale | $149,500 | -25,000 | -98% | $5.98 | 400 | 06 Jun 2025 | Direct | F5 |
| transaction | TGEN | Common Stock | Exercise of in-the-money or at-the-money derivative security | $11,000 | +10,000 | +2500% | $1.10 | 10,400 | 23 Jun 2025 | Direct | F4 |
| transaction | TGEN | Common Stock | Sale | $72,500 | -10,000 | -96% | $7.25* | 400 | 23 Jun 2025 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TGEN | Stock Options (Right to Buy) | Exercise of in-the-money or at-the-money derivative security | $7,100 | -10,000 | -20% | $0.7100 | 40,000 | 03 Jun 2025 | Common Stock | 50,000 | $0.7100 | Direct | F6 |
| transaction | TGEN | Stock Options (Right to Buy) | Exercise of in-the-money or at-the-money derivative security | $10,650 | -15,000 | -38% | $0.7100 | 25,000 | 04 Jun 2025 | Common Stock | 40,000 | $0.7100 | Direct | F6 |
| transaction | TGEN | Stock Options (Right to Buy) | Exercise of in-the-money or at-the-money derivative security | $27,500 | -25,000 | -48% | $1.10 | 27,500 | 06 Jun 2025 | Common Stock | 52,500 | $1.10 | Direct | F7 |
| transaction | TGEN | Stock Options (Right to Buy) | Exercise of in-the-money or at-the-money derivative security | $11,000 | -10,000 | -36% | $1.10 | 17,500 | 23 Jun 2025 | Common Stock | 25,000 | $1.10 | Direct | F7 |
| Id | Content |
|---|---|
| F1 | Shares acquired pursuant to exercise of Stock Option Agreement dated 7/9/2020 |
| F2 | Multiple share sales between $4.75 and $5.25 per share |
| F3 | 10,000 shares sold for $4.90 per share, and 5,000 shares sold for $5.10 per share |
| F4 | Shares acquired pursuant to stock option agreement dated 1/21/2022 |
| F5 | Multiple share sales between $5.85 and $6.10 |
| F6 | Vests 50% upon achievement of Adjusted EBITDA goal of 2% of revenue in two consecutive quarters, and 50% upon achievement of Adjusted EBITDA goal of 3% of revenue in four consecutive quarters |
| F7 | Vests 50% per year |